Christopher D Rodee

Array ( [id] => 18491696 [patent_doc_number] => 11697101 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-07-11 [patent_title] => Method for preparing phospholipid micelles [patent_app_type] => utility [patent_app_number] => 17/979033 [patent_app_country] => US [patent_app_date] => 2022-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1994 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 286 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17979033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18634888 [patent_doc_number] => 11759459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-19 [patent_title] => Treatment of pain by subarachnoid administration of sustained-release liposomal anesthetic compositions [patent_app_type] => utility [patent_app_number] => 17/958780 [patent_app_country] => US [patent_app_date] => 2022-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28586 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18282660 [patent_doc_number] => 20230098132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => NANO-SEEDING [patent_app_type] => utility [patent_app_number] => 17/932757 [patent_app_country] => US [patent_app_date] => 2022-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9172 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17932757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18242653 [patent_doc_number] => 20230074964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => MATERIALS AND METHODS FOR NERVE REPAIR AND REGENERATION [patent_app_type] => utility [patent_app_number] => 17/903918 [patent_app_country] => US [patent_app_date] => 2022-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10029 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17903918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18368172 [patent_doc_number] => 11648321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-05-16 [patent_title] => Compositions and methods for delivery of RNA [patent_app_type] => utility [patent_app_number] => 17/821445 [patent_app_country] => US [patent_app_date] => 2022-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 58 [patent_no_of_words] => 18491 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18603478 [patent_doc_number] => 11744920 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-09-05 [patent_title] => Implant for ovarian decline and methods of manufacturing an implant for ovarian decline [patent_app_type] => utility [patent_app_number] => 17/886773 [patent_app_country] => US [patent_app_date] => 2022-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13304 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18056233 [patent_doc_number] => 20220387319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => MICROPARTICLES AND NANOPARTICLES HAVING NEGATIVE SURFACE CHARGES [patent_app_type] => utility [patent_app_number] => 17/879316 [patent_app_country] => US [patent_app_date] => 2022-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14185 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18574225 [patent_doc_number] => 11730731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-22 [patent_title] => Sustained formulation for prevention or treatment of autoimmune disease containing naltrexone and method using the same [patent_app_type] => utility [patent_app_number] => 17/871428 [patent_app_country] => US [patent_app_date] => 2022-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 90 [patent_no_of_words] => 28721 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18126658 [patent_doc_number] => 20230012279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-12 [patent_title] => HYDROGEL COMPOSITION, HYDROGEL BIOMEDICAL MATERIAL, METHOD FOR FACILITATING REGENERATION OF BONE AND MANUFACTURING METHOD OF HYDROGEL COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/854229 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4320 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17928479 [patent_doc_number] => 20220323604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF RNA [patent_app_type] => utility [patent_app_number] => 17/839574 [patent_app_country] => US [patent_app_date] => 2022-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18521 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17839574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18056249 [patent_doc_number] => 20220387335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => NANOPARTICLES FOR TREATING PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 17/835694 [patent_app_country] => US [patent_app_date] => 2022-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37272 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18056521 [patent_doc_number] => 20220387607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => GLYCAN MODIFIED NUCLEIC ACIDS, METHODS OF PREPARATION, AND THERAPEUTIC USES [patent_app_type] => utility [patent_app_number] => 17/825737 [patent_app_country] => US [patent_app_date] => 2022-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68197 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17825737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18302029 [patent_doc_number] => 11623920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-11 [patent_title] => Process for preparing pitolisant hydrochloride and solid-state forms thereof [patent_app_type] => utility [patent_app_number] => 17/751836 [patent_app_country] => US [patent_app_date] => 2022-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12669 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18171746 [patent_doc_number] => 11571438 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-02-07 [patent_title] => Nutraceutical compositions to up-regulate SIRT1 and methods of use [patent_app_type] => utility [patent_app_number] => 17/751269 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3327 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17981058 [patent_doc_number] => 20220347094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-03 [patent_title] => OCULAR IMPLANT CONTAINING A TYROSINE KINASE INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/744189 [patent_app_country] => US [patent_app_date] => 2022-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74759 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17828376 [patent_doc_number] => 20220265680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS [patent_app_type] => utility [patent_app_number] => 17/729427 [patent_app_country] => US [patent_app_date] => 2022-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18253201 [patent_doc_number] => 20230080240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => DRUG IMPLANTS CONTAINING ENZALUTAMIDE AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/728702 [patent_app_country] => US [patent_app_date] => 2022-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12905 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17759879 [patent_doc_number] => 20220233491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => BISMUTH-THIOL COMPOSITIONS AND METHODS FOR TREATING WOUNDS [patent_app_type] => utility [patent_app_number] => 17/713893 [patent_app_country] => US [patent_app_date] => 2022-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50685 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17713893 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18182397 [patent_doc_number] => 20230043126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => MULTIPURPOSE PRODUCT WITH PROLONGED ANTIMICROBIAL ACTION AND METHOD OF PRODUCING [patent_app_type] => utility [patent_app_number] => 17/710744 [patent_app_country] => US [patent_app_date] => 2022-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3862 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17790599 [patent_doc_number] => 20220249690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF RNA-LIPID NANOPARTICLE COMPLEXES ENCODING FOR VIRAL RNA POLYMERASE REGION AND PROTEIN ANTIGEN [patent_app_type] => utility [patent_app_number] => 17/702730 [patent_app_country] => US [patent_app_date] => 2022-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18492 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702730 [rel_patent_id] =>[rel_patent_doc_number] =>)